Search results

Lege Artis Medicinae

MAY 20, 2019

[Rifaximin-α: More than antibiotic ]

TALLER András

[Antibiotic therapy might alter gut microbiome. The consequence of that is dysbiosis with or without immediate overt clinical manifestation. The beneficial effect of rifaximin, a non-absorbable broad spectrum antibiotic, in gastrointestinal and hepatic disorders is known for a long time. According to recent data rifaximin has not only antibiotic but also anti-inflammatory and, within antibiotics, a unique special eubiotic effect as well. It modulates the gut microbiome, restores eubiosis through increasing beneficial species’ count while not disturbing diversity.]